Page last updated: 2024-12-07

geographutoxin i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gonyautoxin I: structure in first source; RN given refers to gonyautoxin I; gonyantoxin IV is isomer of gonyautoxin I [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

geographutoxin I: toxic peptide from Conus geographus with 22 amino acids; different from conotoxin GI; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID104848
SCHEMBL ID22319914
MeSH IDM0114839
PubMed CID56843427
CHEMBL ID4562161
MeSH IDM0114839

Synonyms (17)

Synonym
gonyautoxin i
gtx i
SCHEMBL22319914
geographutoxin i
mu-conotoxin giiia
86394-16-3
mu-conotoxin g iiia (reduced)
.mu.-conotoxin g iiia
conotoxin g iiia
mu-conotoxin g iiia
129129-65-3
unii-0c5t02ki0e
l-alaninamide, l-arginyl-l-alpha-aspartyl-l-cysteinyl-l-cysteinyl-l-threonyl-(4r)-4-hydroxy-l-prolyl-(4r)-4-hydroxy-l-prolyl-l-lysyl-l-lysyl-l-cysteinyl-l-lysyl-l-alpha-aspartyl-l-arginyl-l-glutaminyl-l-cysteinyl-l-lysyl-(4r)-4-hydroxy-l-prolyl-l
0c5t02ki0e ,
bdbm50520482
CHEMBL4562161 ,
DTXSID101339126

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Therefore, populations utilizing high ammonium concentration could be more toxic than those growing on nitrate or urea."( Variability in toxicity of the dinoflagellate Alexandrium tamarense in response to different nitrogen sources and concentrations.
Leong, SC; Murata, A; Nagashima, Y; Taguchi, S, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium channel protein type 4 subunit alphaRattus norvegicus (Norway rat)IC50 (µMol)0.06900.06900.28450.5000AID1583525
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1583525Inhibition of rat Nav1.4 expressed in HEK293 cells at -80 mV holding potential by whole cell patch-clamp assay2020Journal of medicinal chemistry, 02-27, Volume: 63, Issue:4
Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (18.75)18.7374
1990's3 (18.75)18.2507
2000's3 (18.75)29.6817
2010's6 (37.50)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]